Human Genome Sciences Inc (HGSI) Gross Profit Margin starting from the second quarter 2012 to second quarter 2011, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Human Genome Sciences Inc  (HGSI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Human Genome Sciences Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HGSI Gross Profit Margin (Jun 30 2012)
Q2 		(Mar 31 2012)
Q1 		(Dec 31 2011)
Q4 		(Sep 30 2011)
Q3 		(Jun 30 2011)
Q2
Y / Y Revenue Change 142.75 %
Seq. Revenue Change 28.04 %
Revenue In Millions $60.34
Gross Profit Margin 63.92 %
Gross Profit Margin Total Ranking # 777
Gross Profit In Millions $38.57
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2012 Gross Profit Margin
Human Genome Sciences Inc achieved Gross Profit of $39 millions compare to Gross Loss of $0.00 millions recorded in the previous quarter. Revenue increased by 28.04 % Company accomplished below the average Gross Profit Margin with 63.92 %.


Observing second quarter 2012 results within Medical Laboratories industry 6 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 777.
Learn about Gross Margin
HGSI's Gross Profit Margin second quarter 2012 Company Ranking
Within: No.
Medical Laboratories Industry # 7
Healthcare Sector # 98
Overall # 635

Gross Profit Margin Statistics
High Average Low
63.92 % 63.92 % 63.92 %
(Jun 30 2012)  


HGSI Gross Income Trends • More of HGSI's Profitabilty Ratios • HGSI Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
HGSI's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
HGSI's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for HGSI's Competitors
Gross Profit Margin Profit Margin for Human Genome Sciences Inc's Suppliers
Gross Profit Margin Profit Margin for HGSI's Customers

You may also want to know
HGSI's Annual Growth Rates HGSI's Profitability Ratios HGSI's Asset Turnover Ratio HGSI's Dividend Growth
HGSI's Roe HGSI's Valuation Ratios HGSI's Financial Strength Ratios HGSI's Gross Profit Growth
HGSI's Roa HGSI's Inventory Turnover Ratio HGSI's Growth Rates HGSI's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2012, within Medical Laboratories Industry Gross Profit MarginJun 30 2012 MRQ Gross ProfitJun 30 2012 MRQ Revenue
Incyte Corporation  99.98 %$ 86.526  Millions$ 86.542  Millions
Dyax Corp  97.03 %$ 13.614  Millions$ 14.030  Millions
Hologic Inc  90.17 %$ 423.982  Millions$ 470.228  Millions
Genomic Health Inc  84.36 %$ 48.618  Millions$ 57.631  Millions
Nuo Therapeutics, Inc.  73.41 %$ 2.705  Millions$ 3.685  Millions
Cba Florida Inc   71.29 %$ 1.286  Millions$ 1.804  Millions
Human Genome Sciences Inc  63.92 %$ 38.568  Millions$ 60.342  Millions
Grapefruit Usa Inc   63.27 %$ 0.197  Millions$ 0.311  Millions
Psychemedics Corporation  59.80 %$ 4.103  Millions$ 6.862  Millions
Charles River Laboratories International inc   58.17 %$ 165.620  Millions$ 284.723  Millions
Nrc Health  58.16 %$ 11.999  Millions$ 20.632  Millions
Biocept Inc   49.34 %$ 11.376  Millions$ 23.058  Millions
American Shared Hospital Services  43.72 %$ 1.873  Millions$ 4.284  Millions
Quest Diagnostics Inc  41.76 %$ 796.296  Millions$ 1,906.810  Millions
Labcorp Holdings Inc   40.71 %$ 579.500  Millions$ 1,423.400  Millions
Luna Innovations Inc  38.45 %$ 3.145  Millions$ 8.180  Millions
Inotiv Inc   28.65 %$ 2.059  Millions$ 7.186  Millions
Butterfly Network Inc   19.94 %$ 4.429  Millions$ 22.215  Millions
Radnet Inc   17.42 %$ 28.797  Millions$ 165.351  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.